Investigate / reported ownership
CVS
Cvs Health Corp
12 tracked reported owners · snapshot updated 2026-10-04. Delayed disclosures, not live holdings or an investment recommendation.
Who reports owning CVS?
Select a manager to inspect their portfolio. Reports may cover different quarters; portfolio weights describe disclosed long 13F holdings, not total economic exposure.
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Dodge & Cox Funds | 2.7% | 32q | $5.17B | 50,012,765 |
| 2 | Christopher Davis | 5.3% | 31q | $1.23B | 11,865,916 |
| 3 | Richard Pzena | 3.6% | 31q | $1.22B | 11,769,536 |
| 4 | Joel Greenblatt | 0.3% | 40q | $498M | 4,812,530 |
| 5 | Viking Global Investors | 1.1% | 2q | $379M | 3,663,361 |
Go beyond ownership.
CVS operates retail locations and medical clinics, pharmacy-benefit-management and specialty-pharmacy solutions, and health-insurance products and related services. Its Aetna business offers medical, pharmacy, dental and behavioral-health coverage, including Medicare and Medicaid products.
Question to investigate: Can CVS's combined insurance, pharmacy benefit, care delivery and retail operations work together as intended, while managing cost forecasting, regulation and litigation exposure?
Company research reviewed 2026-10-02; a dated source-linked starting point, not the investors’ stated reasons.
Understand the business and investment case →Filing dates and original SEC sources
- Dodge & Cox Funds · 2026Q2 · filed 2026-08-13 ↗
- Christopher Davis · 2026Q2 · filed 2026-08-11 ↗
- Richard Pzena · 2026Q2 · filed 2026-08-07 ↗
- Joel Greenblatt · 2026Q2 · filed 2026-09-02 ↗
- Viking Global Investors · 2026Q2 · filed 2026-08-14 ↗
- Prem Watsa · 2026Q2 · filed 2026-08-14 ↗
- Samantha McLemore · 2026Q2 · filed 2026-08-13 ↗
- John Rogers · 2026Q2 · filed 2026-08-14 ↗
- Bill Nygren · 2026Q2 · filed 2026-08-14 ↗
- Hillman Capital Management · 2026Q2 · filed 2026-08-14 ↗
- Robert Olstein · 2026Q1 · filed 2026-04-21 ↗
- David Katz · 2026Q2 · filed 2026-07-15 ↗
A material reported change · Q2 2026
Viking Global Investors reported a new position in CVS.
Holdings as of Jun 30, 2026 · filed Aug 14, 2026. Position at period end: 1.1% of the reported portfolio. The filing does not reveal the trade date, price, or reason.
Explore earlier changes and contrasting evidence
Selected historical records. Retrospective outcomes do not establish predictive skill.
Compare the reported increases and reductions →Q2 2026
filed Aug 14, 2026
45d lag
-7.9% vs SPY
34 sessions after disclosure
direction not supported so far
Q2 2026
filed Jul 7, 2026
7d lag
-20.2% vs SPY
62 sessions after disclosure
direction supported so far
Q1 2026
filed May 15, 2026
45d lag
-6.3% vs SPY
63 sessions after disclosure
direction not supported so far
Q3 2025
filed Nov 14, 2025
45d lag
-3.4% vs SPY
63 sessions after disclosure
direction supported so far
Q2 2025
filed Aug 14, 2025
45d lag
+11.4% vs SPY
63 sessions after disclosure
direction not supported so far
Q2 2025
filed Aug 14, 2025
45d lag
+11.4% vs SPY
63 sessions after disclosure
direction supported so far
Keep your next step small.
Save the company and inspect its evidence. Recording a private view is optional and requires a separate, explicit save.
Record my own view →Optional email follow
Latticework Follow
Follow CVS
Email me only when a reviewed weekly edition contains a material new decision about CVS: a new position, exit, or a large share-count change that also clears the size threshold. There may be quiet weeks.
Confirm by email. Manage or stop follows in one click. See our privacy notice.
Long US 13F disclosures omit shorts and can be amended. CUSIP 126650100. No current price, valuation or manager motive is inferred.